Executive Sessions: Washington Outlook 2027

Tuesday, January 19, 2027 (11–11:30 a.m. US/Eastern)
Virtual

Washington Outlook 2027

Erin Smith, Pont Advisory Group

As a new Congress takes shape and the policy landscape continues to evolve, what should leaders in the analytical instruments, life science tools, and diagnostics industries be watching in 2027?

Erin Smith of Pont Advisory Group will provide a practical overview of the most consequential policy, political, and regulatory developments affecting our industry. Topics will include federal research and life science funding, regulation, trade and tariffs, reimbursement, tax policy, and workforce issues.

The discussion will focus on separating meaningful developments from political noise, with particular attention to implications for business strategy, investment, customer demand, supply chains, and growth.

About the Speaker: 

Erin Smith is President of Pont Advisory Group, bringing government affairs and policy leadership experience across the life sciences industry and federal government. She previously served as Director of Public-Private Partnerships at the Advanced Research Projects Agency for Health and held senior government affairs and policy roles at Twist Bioscience and Gilead Sciences. Her background spans health law, public health, and the intersection of government policy and life science innovation.

For more information, please contact:

Carol Starke
Manager, Meetings & Administration
Analytical, Life Science & Diagnostics Association (ALDA)
Phone: (703) 647-6361
Email: CStarke@thealda.org